Illumina Brass Faces Shareholder Suit Over Grail Deal Debacle
Law 360
MARCH 11, 2024
Food and Drug Administration Commissioner Scott Gottlieb, have been hit with a shareholder derivative suit in California federal court over their role in the biotech company's failed $8 billion deal to reacquire its cancer-detection company Grail Inc.
Let's personalize your content